{"filing":{"accession_number":"0001104659-26-092058","cik":"0001526119","ticker":"VSTM","company_name":"Verastem, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"tm2622452d2_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1526119/000110465926092058/tm2622452d2_8k.htm"},"events":[{"id":25449,"run_id":23101,"accession_number":"0001104659-26-092058","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) issued on August 6, 2026. The filing discloses total revenue of $40.1 million (vs. $2.1 million in Q2 2025), net product revenue of $25.1 million from AVMAPKI FAKZYNJA CO-PACK, and a net loss of $34.7 million. The press release is furnished as Exhibit 99.1 and incorporated into Item 2.02, which is the standard Item for results of operations and financial condition. Material to investors as it shows significant revenue growth from the newly commercialized product and cash position updates.","company_name":"Verastem, Inc.","ticker":"VSTM","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26282,"accession_number":"0001104659-26-092058","item_number":"2.02","item_title":"Results of Operations and Financial","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) issued on August 6, 2026. The filing discloses total revenue of $40.1 million (vs. $2.1 million in Q2 2025), net product revenue of $25.1 million from AVMAPKI FAKZYNJA CO-PACK, and a net loss of $34.7 million. The press release is furnished as Exhibit 99.1 and incorporated into Item 2.02, which is the standard Item for results of operations and financial condition. Material to investors as it shows significant revenue growth from the newly commercialized product and cash position updates.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:45:51.136754+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26282,"accession_number":"0001104659-26-092058","item_number":"2.02","item_title":"Results of Operations and Financial","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) issued on August 6, 2026. The filing discloses total revenue of $40.1 million (vs. $2.1 million in Q2 2025), net product revenue of $25.1 million from AVMAPKI FAKZYNJA CO-PACK, and a net loss of $34.7 million. The press release is furnished as Exhibit 99.1 and incorporated into Item 2.02, which is the standard Item for results of operations and financial condition. Material to investors as it shows significant revenue growth from the newly commercialized product and cash position updates.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:45:51.136754+00:00","company_name":"Verastem, Inc.","ticker":"VSTM","filing_date":"2026-08-06"}]}